Effect of Epidural Analgesia on the Length of Labor and Delivery and Fetal Outcomes
- Conditions
- LaborEpidural AnalgesiaNulliparous
- Interventions
- Procedure: epidural analgesia
- Registration Number
- NCT02396563
- Lead Sponsor
- University of Cagliari
- Brief Summary
The purpose of this study is to determine if there is a difference in the duration of the first and second stage of labor in nulliparous women , with or without epidural analgesia. The investigators hypothesize that the duration of the first stage of labor will be no different in nulliparous patients, while the duration of the second stage will be longer in patient with analgesia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
- Nulliparous
- > 18 years old
- term (>37 weeks gestation)
- singleton
- vertex pregnancies
Exclusion Criteria
- Non-vertex presentation
- cervical dilation > 4.0cm
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description epidural analgesia epidural analgesia women in labor with epidural analgesia epidural analgesia Ropivacaine women in labor with epidural analgesia
- Primary Outcome Measures
Name Time Method duration of labor Onset of contractions or rupture of membrances to delivery
- Secondary Outcome Measures
Name Time Method Presence or absence of fetal heart rate decelerations Time of first analgesic dose to 60 minutes fetal tachycardia Time of first analgesic dose to 60 minutes
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which epidural analgesia with ropivacaine influences labor duration in nulliparous women?
How does the use of epidural analgesia compare to other pain management strategies in terms of labor outcomes for nulliparous patients?
Are there specific biomarkers that can predict prolonged second stage of labor following epidural analgesia administration?
What are the potential adverse fetal outcomes associated with epidural analgesia during labor, as observed in NCT02396563?
How do alternative analgesic drugs or combination therapies compare to ropivacaine in managing labor pain and maternal outcomes?